articleScienceNov 28, 2003Closed access

Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus

Centers for Disease Control and Prevention · J. Craig Venter Institute · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus. A clinical isolate of S. aureus with high-level resistance to vancomycin (minimal inhibitory concentration = 1024 microg/ml) was isolated in June 2002. This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated. Additional elements on the plasmid encoded resistance to trimethoprim (dfrA), beta-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants (qacC). Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies…

No related works found for this paper.